Patent details

EP1253932 Title: BOTULINUM TOXIN PHARMACEUTICAL COMPOSITIONS

Basic Information

Publication number:
EP1253932
PCT Application Number:
PCT/US/2001/003641
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019054360
PCT Publication Number:
WO/2001/058472
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BOTULINUM TOXIN PHARMACEUTICAL COMPOSITIONS
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES A BASE DE TOXINE BOTULIQUE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT BOTULINUM TOXIN
SPC Number:

Dates

Filing date:
05/02/2001
Grant date:
27/04/2005
EP Publication Date:
27/04/2005
PCT Publication Date:
16/08/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/11/2002
EP B1 Publication Date:
27/04/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/02/2006
Expiration date:
05/02/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/02/2001
 
 

Name:
Allergan Inc.
Address:
2525 Dupont Drive,, Irvine, CA 92612, United States (US)

Inventor

Name:
HUNT Terrence, J.
Address:
United States (US)

Priority

Priority Number:
500147
Priority Date:
08/02/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/16;
Filing date Document type Number of pages